These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16755881)

  • 1. [Roles of endothelin and its receptors in prostate cancer].
    Wang QB; Qu WS; Qin DS; Wang ZP
    Zhonghua Nan Ke Xue; 2006 May; 12(5):450-2. PubMed ID: 16755881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelin axis: emerging role in cancer.
    Nelson J; Bagnato A; Battistini B; Nisen P
    Nat Rev Cancer; 2003 Feb; 3(2):110-6. PubMed ID: 12563310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelin axis in cancer.
    Bagnato A; Rosanò L
    Int J Biochem Cell Biol; 2008; 40(8):1443-51. PubMed ID: 18325824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-endothelin drugs in solid tumors.
    Russo A; Bronte G; Rizzo S; Fanale D; Di Gaudio F; Gebbia N; Bazan V
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):27-40. PubMed ID: 20102289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy.
    Bagnato A; Spinella F; Rosanò L
    Can J Physiol Pharmacol; 2008 Aug; 86(8):473-84. PubMed ID: 18758494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine prostate stimulates osteoblast function using the endothelin receptors.
    LeRoy BE; Sellers RS; Rosol TJ
    Prostate; 2004 May; 59(2):148-56. PubMed ID: 15042615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
    Carducci MA; Jimeno A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6296s-6300s. PubMed ID: 17062717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor antagonism and cancer.
    Bhalla A; Haque S; Taylor I; Winslet M; Loizidou M
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():74-7. PubMed ID: 19335749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A; Jurzak M; Gojniczek K
    Wiad Lek; 2008; 61(4-6):126-34. PubMed ID: 18939363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054.
    Growcott JW
    Anticancer Drugs; 2009 Feb; 20(2):83-8. PubMed ID: 19065106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonists as therapeutic agents for cancer.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1234-9. PubMed ID: 12211422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 as a target for therapeutic intervention in prostate cancer.
    Kopetz ES; Nelson JB; Carducci MA
    Invest New Drugs; 2002 May; 20(2):173-82. PubMed ID: 12099577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1-induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options.
    Hans G; Deseure K; Adriaensen H
    Neuropeptides; 2008 Apr; 42(2):119-32. PubMed ID: 18194815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelins: possibly a new pharmacological approach in cardiovascular diseases, kidney diseases and oncological disorders].
    Kroodsma JM; Rabelink AJ
    Ned Tijdschr Geneeskd; 1997 Sep; 141(38):1806-10. PubMed ID: 9545734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications.
    Warner TD
    Eur Heart J; 1993 Nov; 14 Suppl I():42-7. PubMed ID: 8293780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelins in animal models of hypertension: focus on cardiovascular protection.
    Moreau P; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Jun; 81(6):511-21. PubMed ID: 12839263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics.
    Thakkar SG; Choueiri TK; Garcia JA
    Curr Oncol Rep; 2006 Mar; 8(2):108-13. PubMed ID: 16507220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endothelins in the regulation of pituitary function.
    Lange M; Pagotto U; Renner U; Arzberger T; Oeckler R; Stalla GK
    Exp Clin Endocrinol Diabetes; 2002 May; 110(3):103-12. PubMed ID: 12012269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
    Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.